Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
The American Journal of Psychiatry|August 1, 1981
Physostigmine and lithium response in the schizophreniasP Edelstein, J R Schultz, J Hirschowitz, et al.The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.Journal of Clinical Psychopharmacology|June 1, 1984
Haloperidol plasma and red blood cell levels and clinical antipsychotic responseD L Garver, J Hirschowitz, G A Glicksteen, et al.Archives of General Psychiatry|May 1, 1984
Lithium ratio in vitro. Diagnosis and lithium carbonate response in psychotic patientsD L Garver, R Hitzemann, J HirschowitzLife Sciences|November 1, 1982
Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked eventsD L Garver, C Johnson, D R KanterThe American Journal of Psychiatry|May 1, 1982
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophreniaJ Hirschowitz, F P Zemlan, D L GarverJournal of Affective Disorders|May 1, 1986
On the physical properties of red cell ghost membranes in the affective disorders and psychoses. A fluorescence polarization studyR J Hitzemann, J Hirschowitz, D L GarverPsychiatry Research|April 1, 1984
Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapyF P Zemlan, J Hirschowitz, D L GarverPageof 18